Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30.

Article  Google Scholar 

Desnick RJ, Ioannou YA. α-Galactosidase a deficiency. Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001.

Google Scholar 

Lenders M, Brand E. Fabry disease: the current treatment landscape. Drugs. 2021;81(6):635–45.

Article  CAS  Google Scholar 

Lee CL, Lin SP, Niu DM, Lin HY. Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) improvement: a review and meta-analysis. Int J Med Sci. 2022;19(1):126–31.

Article  CAS  Google Scholar 

Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, et al. Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab. 2018;123(4):416–27.

Article  CAS  Google Scholar 

Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med. 2007;146(2):77–86.

Article  Google Scholar 

Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Stork S, et al. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009;119(4):524–9.

Article  CAS  Google Scholar 

Reisin R, Perrin A, Garcia-Pavia P. Time delays in the diagnosis and treatment of Fabry disease. Int J Clin Pract. 2017;71(1).

Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassmann G, et al. Clinical manifestations of Fabry disease in children: data from the Fabry outcome survey. Acta Paediatr. 2006;95(1):86–92.

Article  Google Scholar 

Battaglia Y, Fiorini F, Azzini C, Esposito P, De Vito A, Granata A, et al. Deficiency in the screening process of fabry disease: analysis of chronic kidney patients not on dialysis. Front Med (Lausanne). 2021;8:640876.

Article  Google Scholar 

West M, Nicholls K, Mehta A, Clarke JT, Steiner R, Beck M, et al. Agalsidase alfa and kidney dysfunction in Fabry disease. J Am Soc Nephrol. 2009;20(5):1132–9.

Article  CAS  Google Scholar 

Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore). 2002;81(2):122–38.

Article  CAS  Google Scholar 

Pan X, Ouyang Y, Wang Z, Ren H, Shen P, Wang W, et al. Genotype: a crucial but not unique factor affecting the clinical phenotypes in Fabry disease. PLoS One. 2016;11(8):e0161330.

Article  Google Scholar 

Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C, et al. Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol. 2011;11:61.

Article  Google Scholar 

Del Pinto R, Ferri C. The role of immunity in Fabry disease and hypertension: a review of a novel common pathway. High Blood Press Cardiovasc Prev. 2020;27(6):539–46.

Article  Google Scholar 

Kleinert J, Dehout F, Schwarting A, de Lorenzo AG, Ricci R, Kampmann C, et al. Prevalence of uncontrolled hypertension in patients with Fabry disease. Am J Hypertens. 2006;19(8):782–7.

Article  Google Scholar 

Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, et al. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant. 2009;24(7):2102–11.

Article  Google Scholar 

Pisani A, PetruzzelliAnnicchiarico L, Pellegrino A, Bruzzese D, Feriozzi S, Imbriaco M, et al. Parapelvic cysts, a distinguishing feature of renal Fabry disease. Nephrol Dial Transplant. 2018;33(2):318–23.

Article  CAS  Google Scholar 

Sethuraman G, Chouhan K, Kaushal S, Sharma VK. Fabry’s disease. Lancet. 2011;378(9798):1254.

Article  Google Scholar 

Shimohata H, Ogawa Y, Maruyama H, Hirayama K, Kobayashi M. A renal variant of Fabry disease diagnosed by the presence of urinary mulberry cells. Intern Med. 2016;55(23):3475–8.

Article  Google Scholar 

Vujkovac B, SrebotnikKirbis I, Keber T, CokanVujkovac A, Tretjak M, Rados KS. Podocyturia in Fabry disease: a 10-year follow-up. Clin Kidney J. 2022;15(2):269–77.

Article  CAS  Google Scholar 

Sessa A, Meroni M, Battini G, Maglio A, Brambilla PL, Bertella M, et al. Renal pathological changes in Fabry disease. J Inherit Metab Dis. 2001;24(Suppl 2):66–70. discussion 65.

Article  Google Scholar 

Lu Z, Wang Y, Gao L, Lin L, Hu L, Mao J. Early onset of nephrogenic diabetes insipidus due to fabry disease in a child with GLA N215S mutation: Case report and literature review. Heliyon. 2023;9(5):e15993.

Article  CAS  Google Scholar 

Silva CAB, Moura-Neto JA, Dos Reis MA, Vieira Neto OM, Barreto FC. Renal manifestations of Fabry disease: a narrative review. Can J Kidney Health Dis. 2021;8:2054358120985627.

Article  Google Scholar 

Vujkovac B. Fabry disease: diagnostic methods in nephrology practice. Clin Nephrol. 2017;88(13):44–7.

Article  Google Scholar 

Boutin M, Lavoie P, Abaoui M, Auray-Blais C. Tandem mass spectrometry quantitation of lyso-Gb3 and six related analogs in plasma for Fabry disease patients. Curr Protoc Hum Genet. 2016;90:17.23.1-17.23.9.

Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.

Article  Google Scholar 

Peces R, Mena R, Peces C, Cuesta E, Selgas R, Barruz P, et al. Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: a model of early-onset and fast cyst progression. Clin Genet. 2020;97(6):857–68.

Article  CAS  Google Scholar 

Ebner K, Reintjes N, Feldkotter M, Korber F, Nagel M, Dotsch J, et al. A case report on the exceptional coincidence of two inherited renal disorders: ADPKD and Alport syndrome. Clin Nephrol. 2017;88(1):45–51.

Article  Google Scholar 

Hao W, Ao L, Zhang C, Zhu L, Xie D. IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report. J Int Med Res. 2020;48(3):300060519891290.

Article  Google Scholar 

Ren H, Li L, Yu J, Wu S, Zhou S, Zheng Y, Sun W. Fabry disease and immunoglobulin A nephropathy presenting with Alport syndrome-like findings: a case report. Medicine (Baltimore). 2019;98(28):e16256.

Article  Google Scholar 

Johar L, Lee G, Martin-Rios A, Hall K, Cheng C, Lombardo D, et al. Polycystic kidney disease complicates renal pathology in a family with Fabry disease. Mol Genet Metab Rep. 2022;33:100934.

CAS  Google Scholar 

Salerno FR, Roggero L, Rossi F, Binaggia A, Bertoli S, Pieruzzi F. Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy. Clin Kidney J. 2022;15(1):171–3.

Article  Google Scholar 

Zarate YA, Patterson L, Yin H, Hopkin RJ. A case of minimal change disease in a Fabry patient. Pediatr Nephrol. 2010;25(3):553–6.

Article  Google Scholar 

Yang N, Wang X, Xu F, Zeng C, Wang J, Liu Z. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients. Clin Nephrol. 2017;87(4):188–95.

Article  CAS  Google Scholar 

Chao CT, Lin WC, Kao TW. Fabry disease and immunoglobulin A nephropathy. Nephrology (Carlton). 2012;17(8):782–3.

Article  Google Scholar 

Yin G, Wu Y, Zeng CH, Chen HP, Liu ZH. Coexistence of Fabry disease and IgA nephropathy: a report of two cases. Ir J Med Sci. 2014;183(4):671–5.

Article  CAS  Google Scholar 

Liu Y, Xie H, Lin H, Chen S, Wang W, Zhao G, Zhang X. Coexistence of Fabry disease and membranous nephropathy. Iran J Kidney Dis. 2016;10(1):48–50.

Google Scholar 

Zhou W, Ni Z, Zhang M. Hemizygous Fabry disease associated with membranous nephropathy: a rare case report. Clin Nephrol. 2018;90(3):227–31.

Article  Google Scholar 

Kanai T, Ito T, Aoyagi J, Yamagata T. Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-beta and carbamazepine: a case report. Medicine (Baltimore). 2022;101(7):e28830.

Article  Google Scholar 

Singh HK, Nickeleit V, Kriegsmann J, Harris AA, Jennette JC, Mihatsch MJ. Coexistence of Fabry’s disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol. 2001;55(1):73–9.

CAS  Google Scholar 

Shimazu K, Tomiyoshi Y, Aoki S, Sakemi T, Sugihara H. Crescentic glomerulonephritis in a patient with heterozygous Fabry’s disease. Nephron. 2002;92(2):456–8.

Article  Google Scholar 

Kriegsmann J, Otto M, Wandel E, Schwarting A, Faust J, Hansen T, et al. Fabry’s disease, glomerulonephritis with crescentic and granulomatous interstitial nephritis Case of one family. Pathologe. 2003;24(6):439–43.

Article  CAS  Google Scholar 

Wu H, Behera TR, Gong J, Shen Q. Coexistence of Fabry disease with IgM nephropathy: a case report. Medicine (Baltimore). 2019;98(41):e17566.

Article  Google Scholar 

Stenvinkel P, Chertow GM, Devarajan P, Levin A, Andreoli SP, Bangalore S, Warady BA. Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Rep. 2021;6(7):1775–87.

Article  Google Scholar 

Cornec-Le Gall E, Audrezet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, et al. PKD2-related autosomal dominant polycystic kidney disease: prevalence, clinical presentation, mutation spectrum, and prognosis. Am J Kidney Dis. 2017;70(4):476–85.

Article  CAS  Google Scholar 

Vardarli I, Rischpler C, Herrmann K, Weidemann F. Diagnosis and screening of patients with fabry disease. Ther Clin Risk Manag. 2020;16:551–8.

Article  CAS  Google Scholar 

Wanner C, Oliveira JP, Ortiz A, Mauer M, Germain DP, Linthorst GE, et al. Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol. 2010;5(12):2220–8.

Article  Google Scholar 

Laney DA, Bennett RL, Clarke V, Fox A, Hopkin RJ, Johnson J, et al. Fabry disease practice guidelines: recommendations of the National Society of Ge